Evicenter
P&T meetings

Deramiocel (CAP-1002)

Duchenne muscular dystrophy

Launch
Not announced
Last updated
92 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Histone deacetylase inhibitors

2 evidence topics · 1 source

Givinostat: therapeutic class and treated age range

“histone deacetylase (HDAC) inhibitor” (opens the source at this quote in a new tab)

“patients six years of age and older.” (opens the source at this quote in a new tab)

Other treatment options: givinostat

“Duvyzat is the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.” (opens the source at this quote in a new tab)